ImmunityBio, Inc. (IBRX)
8.64
-0.13
(-1.48%)
USD |
NASDAQ |
Oct 21, 16:00
8.58
-0.06
(-0.69%)
After-Hours: 04:27
ImmunityBio Net Income (Annual) : -351.47M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -351.47M |
| December 31, 2024 | -413.64M |
| December 31, 2023 | -583.85M |
| December 31, 2022 | -417.32M |
| December 31, 2021 | -349.85M |
| December 31, 2020 | -92.38M |
| December 31, 2019 | -65.79M |
| Date | Value |
|---|---|
| December 31, 2018 | -96.23M |
| December 31, 2017 | -96.42M |
| December 31, 2016 | -120.81M |
| December 31, 2015 | -236.88M |
| December 31, 2014 | -6.185M |
| December 31, 2013 | -2.047M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Moderna, Inc. | -2.822B |
| Sarepta Therapeutics, Inc. | -713.41M |
| Arrowhead Pharmaceuticals, Inc. | 30.11M |
| Oncolytics Biotech, Inc. | -28.76M |
| Sangamo Therapeutics, Inc. | -122.93M |